Lipocine Inc. (LPCN) › Shareholders' EquityLipocine Inc. (LPCN) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: $1.30M2012: $5.32M2013: $44.82M2014: $26.36M2015: $41.99M2016: $26.02M2017: $18.98M2018: $9.43M2019: $6.29M2020: $15.34M2021: $45.57M2022: $35.63M2023: $20.37M2024: $21.00M2025: $14.48M$14.48M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$14.48M-31.1%2024$21.00M+3.1%2023$20.37M-42.8%2022$35.63M-21.8%2021$45.57M+197.0%2020$15.34M+144.0%2019$6.29M-33.3%2018$9.43M-50.3%2017$18.98M-27.0%2016$26.02M-38.0%2015$41.99M+59.3%2014$26.36M-41.2%2013$44.82M+743.2%2012$5.32M+308.4%2011$1.30M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share